Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate Cancer

Abstract

No AccessJournal of UrologyClinical Urology: Special Communication1 Dec 1995Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate Cancer Richard G. Middleton, Ian M. Thompson, Mark S. Austenfeld, William H. Cooner, Roy J. Correa, Robert P. Gibbons, Harry C. Miller, Joseph E. Oesterling, Martin I. Resnick, Stephen R. Smalley, and John H. Wasson Richard G. MiddletonRichard G. Middleton , Ian M. ThompsonIan M. Thompson , Mark S. AustenfeldMark S. Austenfeld , William H. CoonerWilliam H. Cooner , Roy J. CorreaRoy J. Correa , Robert P. GibbonsRobert P. Gibbons , Harry C. MillerHarry C. Miller , Joseph E. OesterlingJoseph E. Oesterling , Martin I. ResnickMartin I. Resnick , Stephen R. SmalleyStephen R. Smalley , and John H. WassonJohn H. Wasson View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)66718-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The American Urological Association convened the Prostate Cancer Clinical Guidelines Panel to analyze the literature regarding available methods for treating locally confined prostate cancer, and to make practice policy recommendations based on the treatment outcomes data insofar as the data permit. Materials and Methods: The panel searched the MEDLINE data base for all articles from 1966 to 1993 on stage T2 (B) prostate cancer and systematically analyzed outcomes data for radical prostatectomy, radiation therapy and surveillance as treatment alternatives. Outcomes considered most important were survival at 5, 10 and 15 years, progression at 5, 10 and 15 years, and treatment complications. Results: The panel found the outcomes data inadequate for valid comparisons of treatments. Differences were too great among treatment series with regard to such significant characteristics as age, tumor grade and pelvic lymph node status. The panel elected to display, in tabular form and graphically, the ranges in outcomes data reported for each treatment alternative. Conclusions: In making its recommendations, the panel presented treatment alternatives as options, identifying the advantages and disadvantages of each, and recommended as a standard that patients with newly diagnosed, clinically localized prostate cancer should be informed of all commonly accepted treatment options. References 1 : Prostate Cancer Clinical Guidelines Panel: Report on the Management of Clinically Localized Prostate Cancer.. Baltimore: American Urological Association, Inc.1995. Google Scholar 2 : A Manual for Assessing Health Practices & Designing Practice Policies: The Explicit Approach. Philadelphia: American College of Physicians1992. Google Scholar 3 AAFP Positions on the Clinical Aspects of Medical Practice.. Kansas City: American Academy of Family Physicians1995. Google Scholar © 1995 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byRitchey J, Gay E, Spencer B, Miller D, Wallner L, Stewart A, Dunn R, Litwin M and Wei J (2012) Assessment of the Quality of Medical Care Among Patients with Early Stage Prostate Cancer Undergoing Expectant Management in the United StatesJournal of Urology, VOL. 188, NO. 3, (769-774), Online publication date: 1-Sep-2012.Chamie K, Sadetsky N and Litwin M (2011) Physician Assessment of Pretreatment Functional Status: A Process-Outcomes LinkJournal of Urology, VOL. 185, NO. 4, (1229-1233), Online publication date: 1-Apr-2011.Dahm P, Yeung L, Chang S and Cookson M (2008) A Critical Review of Clinical Practice Guidelines for the Management of Clinically Localized Prostate CancerJournal of Urology, VOL. 180, NO. 2, (451-460), Online publication date: 1-Aug-2008.Burnett A, Aus G, Canby-Hagino E, Cookson M, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg S, Hernandez J, Higano C, Kraus S, Liebert M, Moul J, Tangen C, Thrasher J and Thompson I (2007) Erectile Function Outcome Reporting After Clinically Localized Prostate Cancer TreatmentJournal of Urology, VOL. 178, NO. 2, (597-601), Online publication date: 1-Aug-2007.Thompson I, Thrasher J, Aus G, Burnett A, Canby-Hagino E, Cookson M, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg S, Hernandez J, Higano C, Kraus S, Moul J and Tangen C (2018) Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, VOL. 177, NO. 6, (2106-2131), Online publication date: 1-Jun-2007.Cookson M, Aus G, Burnett A, Canby-Hagino E, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg S, Hernandez J, Higano C, Kraus S, Moul J, Tangen C, Thrasher J and Thompson I (2018) Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical OutcomesJournal of Urology, VOL. 177, NO. 2, (540-545), Online public